Publication | Closed Access
Reduction of Liver Steatosis and Fibrosis with an Ask1 Inhibitor in a Murine Model of Nash is Accompanied by Improvements in Cholesterol, Bile Acid and Lipid Metabolism
48
Citations
0
References
2016
Year
Metabolic SyndromeHepatologyMedicineLiver PhysiologyMurine ModelLiver SteatosisPathologyHepatology InflammationHepatotoxicityLiver DiseaseHepatology FibrosisFatty Liver DiseasePharmacologyAsk1 InhibitorHealth Sciences
No additional data available for this publication yet. Check back later!